JANX vs. USLM
JANX (Janux Therapeutics, Inc.) and USLM (United States Lime & Minerals, Inc.) are both stocks. JANX operates in Biotechnology (Healthcare), while USLM operates in Building Materials (Basic Materials). Over the past 5 years, JANX returned -9.69%/yr vs 31.07%/yr for USLM. At a 0.21 correlation, their price movements are largely independent.
Performance
JANX vs. USLM - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, JANX achieves a 8.04% return, which is significantly higher than USLM's -11.52% return.
JANX
- 1D
- 3.97%
- 1M
- 2.69%
- YTD
- 8.04%
- 6M
- 5.59%
- 1Y
- -34.83%
- 3Y*
- 6.05%
- 5Y*
- -9.69%
- 10Y*
- —
USLM
- 1D
- -4.76%
- 1M
- -0.20%
- YTD
- -11.52%
- 6M
- -18.20%
- 1Y
- 8.68%
- 3Y*
- 40.50%
- 5Y*
- 31.07%
- 10Y*
- 26.12%
JANX vs. USLM - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
JANX Janux Therapeutics, Inc. | 8.04% | -74.22% | 398.97% | -18.53% | -33.25% | -41.97% |
USLM United States Lime & Minerals, Inc. | -11.52% | -9.59% | 188.91% | 64.34% | 9.84% | -9.06% |
Correlation
The correlation between JANX and USLM is 0.24, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.24 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.20 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.21 |
Correlation (All Time) Calculated using the full available price history since Jun 11, 2021 | 0.21 |
Fundamentals
JANX:
-$1.84
USLM:
$6.07
JANX:
42.87
USLM:
6.18
JANX:
$21.61M
USLM:
$369.31M
JANX:
$8.44M
USLM:
$177.91M
JANX:
-$134.03M
USLM:
$185.83M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
JANX vs. USLM — Risk / Return Rank
JANX
USLM
JANX vs. USLM - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Janux Therapeutics, Inc. (JANX) and United States Lime & Minerals, Inc. (USLM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| JANX | USLM | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.69 | ||
| Sortino ratioReturn per unit of downside risk | -0.67 | ||
| Omega ratioGain probability vs. loss probability | 0.98 | 1.08 | -0.10 |
| Calmar ratioReturn relative to maximum drawdown | -0.54 | 0.33 | -0.87 |
| Martin ratioReturn relative to average drawdown | -0.78 | 0.73 | -1.52 |
Loading charts...
Drawdowns
JANX vs. USLM - Drawdown Comparison
The maximum JANX drawdown since its inception was -83.14%, which is greater than USLM's maximum drawdown of -77.09%. Use the drawdown chart below to compare losses from any high point for JANX and USLM.
Loading charts...
Drawdown Indicators
| JANX | USLM | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -83.14% | -77.09% | -6.05% |
Max Drawdown (1Y)Largest decline over 1 year | -64.94% | -26.55% | -38.39% |
Max Drawdown (3Y)Largest decline over 3 years | -81.78% | -45.87% | -35.91% |
Max Drawdown (5Y)Largest decline over 5 years | -83.14% | -45.87% | -37.27% |
Max Drawdown (10Y)Largest decline over 10 years | — | -45.87% | — |
Current DrawdownCurrent decline from peak | -77.69% | -32.56% | -45.13% |
Average DrawdownAverage peak-to-trough decline | -52.77% | -27.35% | -25.42% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 44.49% | 11.84% | +32.65% |
Volatility
JANX vs. USLM - Volatility Comparison
The current volatility for Janux Therapeutics, Inc. (JANX) is 10.11%, while United States Lime & Minerals, Inc. (USLM) has a volatility of 10.84%. This indicates that JANX experiences smaller price fluctuations and is considered to be less risky than USLM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| JANX | USLM | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.11% | 10.84% | -0.73% |
Volatility (6M)Calculated over the trailing 6-month period | 29.54% | 32.28% | -2.74% |
Volatility (1Y)Calculated over the trailing 1-year period | 73.95% | 40.58% | +33.37% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 130.70% | 36.03% | +94.67% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 131.21% | 36.44% | +94.77% |
Dividends
JANX vs. USLM - Dividend Comparison
JANX has not paid dividends to shareholders, while USLM's dividend yield for the trailing twelve months is around 0.23%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
JANX Janux Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
USLM United States Lime & Minerals, Inc. | 0.23% | 0.20% | 0.15% | 0.35% | 0.57% | 0.50% | 0.56% | 6.52% | 0.76% | 0.70% | 0.66% | 0.91% |
Financials
JANX vs. USLM - Financials Comparison
This section allows you to compare key financial metrics between Janux Therapeutics, Inc. and United States Lime & Minerals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
JANX and USLM have a correlation of 0.24, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
USLM has higher volatility (10.84%) compared to JANX (10.11%). In terms of maximum drawdown, JANX dropped -83.14% vs USLM's -77.09%.
USLM currently has the higher Sharpe Ratio (0.22 vs -0.47), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for JANX and USLM
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer